Management of Diabetes in Obese Patients

Introduction to Treatment Options

• Sulfonylureas like glipizide are associated with weight gain, which is particularly problematic for obese patients, and when choosing glucose-lowering medications for patients with obesity, consider medications' effect on weight 1

Preferred Medications for Obese Patients

• The American Diabetes Association recommends GLP-1 receptor agonists, such as semaglutide, for patients with obesity and poorly controlled diabetes due to their superior weight loss effects 2, 3
• SGLT2 inhibitors are beneficial for cardiovascular and renal protection, and can be used alongside other diabetes medications, providing weight loss benefits 4

Treatment Guidelines

• Assess glycemic response within 3 months of starting therapy, and monitor both fasting and postprandial glucose levels 4
• If A1c reduction is <0.5% after 3 months at maximum tolerated dose, consider adding or switching to alternative agents 4

Considerations for Glipizide Use

• Unlike GLP-1 receptor agonists and SGLT2 inhibitors, glipizide typically causes weight gain, which can worsen obesity 1, 4

Special Patient Populations

• For patients with very high A1c (>10%) and symptoms of hyperglycemia, consider insulin therapy initially to reverse glucose toxicity 4